Literature DB >> 7833148

Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridisation.

G A Thomas1, M A Barrand, S Stewart, P H Rabbitts, E D Williams, P R Twentyman.   

Abstract

In a number of cell lines with a multidrug resistant phenotype, there is no overexpression of the putative efflux pump, P-glycoprotein. Some such lines do, however, overexpress the MRP gene which encodes a protein bearing considerable amino acid homology to P-glycoprotein. We have used in situ hybridisation to study expression of the MRP gene in human cell lines, lung tumours (representing all the major histologies) and normal lung tissue. Considerable heterogeneity of expression was seen in parental cell line COR-L23/P whereas relatively uniform high-level expression was seen in the resistant line COR-L23/R. Normal bronchial epithelium was strongly positive, but the major epithelial component of all eight lung tumours studied showed only a negative to weak signal. However, the leading edge of the tumours consistently produced a more intense signal similar to that in normal epithelium. Areas of lymphocytic infiltrate were more strongly positive than the tumour epithelium. These results suggest that expression of the MRP gene may be a significant factor determining response of lung tumours to chemotherapy, but that considerable caution is needed in the interpretation of expression studies carried out on homogenised tissue biopsies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7833148     DOI: 10.1016/0959-8049(94)00290-l

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

1.  Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols.

Authors:  K Zhang; K P Wong
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

2.  ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2.

Authors:  G Jedlitschky; I Leier; U Buchholz; J Hummel-Eisenbeiss; B Burchell; D Keppler
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

3.  Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.

Authors:  Walter Berger; Ulrike Setinek; Peter Hollaus; Thomas Zidek; Elisabeth Steiner; L Elbling; H Cantonati; Johannes Attems; Andrea Gsur; Michael Micksche
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-27       Impact factor: 4.553

4.  Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans.

Authors:  A Broeks; B Gerrard; R Allikmets; M Dean; R H Plasterk
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

5.  Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.

Authors:  Margaretha van der Deen; Hendrik Marks; Brigitte W M Willemse; Dirkje S Postma; Michael Müller; Egbert F Smit; George L Scheffer; Rik J Scheper; Elisabeth G E de Vries; Wim Timens
Journal:  Virchows Arch       Date:  2006-10-27       Impact factor: 4.064

6.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Multidrug resistance-associated protein-1 (MRP1) genetic variants, MRP1 protein levels and severity of COPD.

Authors:  Simona E Budulac; Dirkje S Postma; Pieter S Hiemstra; Lisette I Z Kunz; Mateusz Siedlinski; Henriette A Smit; Judith M Vonk; Bea Rutgers; Wim Timens; H Marike Boezen
Journal:  Respir Res       Date:  2010-05-20

8.  Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.

Authors:  Shuang Liu; Young-Seung Kim; Shizhen Zhai; Jiyun Shi; Guihua Hou
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

9.  Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein.

Authors:  Fa Yun Zhang; Gang Jun Du; Ling Zhang; Chun Ling Zhang; Wan Liang Lu; Wei Liang
Journal:  Pharm Res       Date:  2008-12-10       Impact factor: 4.200

10.  Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.

Authors:  Elena V Batrakova; Shu Li; Valery Yu Alakhov; William F Elmquist; Donald W Miller; Alexander V Kabanov
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.